The phenomenon was then discovered in HNSCC, glioma, and gastric cells in vitro experiments, and meanwhile the downregulation of IFITM1 significantly decreased the activity of matrix metalloproteinase 9 (MM9) (44, 47). The gene discussed is IFITM1; the disease is glioma.